Biotech stock Alvotech SA (NASDAQ:ALVO) is plummeting to three-year lows, down 29.9% at $5.36 at last check. The FDA declined to approve the company's arthritis drug, sending a list of deficiencies ...

Analysts have yet to make any adjustments on CIFR today, though the stock saw a slew of price-target hikes last month. Of the 13 analysts in coverage, 10 carry a "buy" or better rating, with three a ...

At last check, IREN was up 19% to trade at $72.27, on track for its biggest single-session gain in nearly a year. The stock ...

Advanced Micro Devices Inc (NASDAQ:AMD) stock is up 1.2% ahead of the bell, enjoying sector tailwinds as investors prepare for the chipmaker's third-quarter report, due out after the close tomorrow.

And tech heavyweights reported earnings, with little net impact on the S&P 500 Index (SPX -- 6,840.20). Meta Platforms (META) and Microsoft (MSFT) experienced significant negative reactions, but those ...